Patterns of publicly funded naltrexone use among patients diagnosed with alcohol use disorder in Ontario
Tourchian N, McCormack D, Leece P, Tadrous M, Gomes T. Alcohol Alcohol. 2024; 59(2):agad091. Epub 2024 Jan 31.
Publications
Palliative end-of-life medication prescribing rates in long-term care: a retrospective cohort study
Tanuseputro P, Roberts R, Milani C, Clarke AE, Webber C, Isenberg SR, Kobewka D, Turcotte L, Bush SH, Boese K, Arya A, Robert B, Sinnarajah A, Simon JE, Howard M, Lau J, Qureshi D, Fremont D, Downar J. J Am Med Dir Assoc. 2024; Jan 16 [Epub ahead of print].
High-sensitivity cardiac troponin I for long-term cardiovascular risk stratification in a cancer clinic population
Kavsak PA, Cerasuolo JO, Kirkwood D, Perez R, Seow H, Ma J, Worster A, Ko DT, Dhesy-Thind S, Leong D. JACC CardioOncol. 2024; Jan 16 [Epub ahead of print].
Impact of COVID-19 pandemic on prescription stimulant use among children and youth: a population-based study
Antoniou T, Pajer K, Gardner W, Penner M, Lunsky Y, McCormack D, Tadrous M, Mamdani M, Gozdyra P, Juurlink DN, Gomes T. Eur Child Adolesc Psychiatry. 2024; Jan 5 [Epub ahead of print].
Opioid agonist treatment retention among people initiating methadone and buprenorphine across diverse demographic and geographic subgroups in Ontario: a population-based retrospective cohort study
Elnagdi A, McCormack D, Bozinoff N, Tadrous M, Antoniou T, Munro C, Campbell T, Paterson JM, Mamdani M, Sproule B, Gomes T. Can J Addict. 2023; 14(4):p 44-54. Epub 2023 Dec 29.
Youth cannabis use and subsequent health service use for mood and anxiety disorders: a population-based cohort study
McDonald AJ, Kurdyak P, Rehm J, Roerecke M, Bondy SJ. Psychiatry Res. 2024; 332:115694. Epub 2023 Dec 25.
New antipsychotic prescription and recurrent infections among adult sepsis survivors: a population-based cohort study
Ferraris A, Szmulewicz AG, Burry L, Phipps A, Wunsch H, Scales DC, Angriman F. Pharmacoepidemiol Drug Saf. 2023; Dec 21 [Epub ahead of print].
Initiations of safer supply hydromorphone increased during the COVID-19 pandemic in Ontario: an interrupted time series analysis
Young S, Gomes T, Kolla G, McCormack D, Dodd Z, Raboud J, Bayoumi AM. PLoS One. 2023; 18(12):e0295145. Epub 2023 Dec 19.
Initiation of opioid agonist therapy after hospital visits for opioid poisonings in Ontario
Hu T, McCormack D, Juurlink DN, Campbell TJ, Bayoumi AM, Leece P, Kent JT, Gomes T. CMAJ. 2023;
Socioeconomic status and access to mental health care: the case of psychiatric medications for children in Ontario Canada
Currie J, Kurdyak P, Zhang J. J Health Econ. 2024; 93:102841. Epub 2023 Dec 12.